Previous close | 43.02 |
Open | 42.99 |
Bid | 45.27 x 100 |
Ask | 45.43 x 100 |
Day's range | 42.70 - 45.40 |
52-week range | 5.65 - 65.60 |
Volume | |
Avg. volume | 1,158,373 |
Market cap | 2.352B |
Beta (5Y monthly) | 3.87 |
PE ratio (TTM) | N/A |
EPS (TTM) | -1.20 |
Earnings date | 06 Aug 2024 - 12 Aug 2024 |
Forward dividend & yield | N/A (N/A) |
Ex-dividend date | N/A |
1y target est | 72.17 |
There's no doubt that money can be made by owning shares of unprofitable businesses. Indeed, Janux Therapeutics...
Detailed Analysis of Janux Therapeutics' First Quarter 2024 Financials and Business Updates
SAN DIEGO, May 07, 2024--Janux Therapeutics Reports First Quarter 2024 Financial Results and Business Highlights